Literature DB >> 29235615

[Music therapy as a non-pharmacological treatment in Alzheimer's disease. A systematic review].

N Garcia-Casares1,2, R M Moreno-Leiva1, J A Garcia-Arnes1.   

Abstract

INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disease which involves, among other manifestations, a progressive deterioration of memory and language, as well as behavioral disorders. In addition to non-curative pharmacological therapies, for the last years, music therapy has been developed as an effective non-pharmacological therapy in order to relieve many of these manifestations. AIM: To analyze the recent scientific evidence about the effect of music therapy on cognitive and behavioral symptoms in patients with AD. PATIENTS AND METHODS: A systematic review has been carried out by means of a bibliographical research using the database PubMed and Science Direct. The key words used for this search were 'Alzheimer's disease' and 'music therapy', as well as the boolean operator 'AND'. We selected those publications between January 2006 and December 2016 and after inclusion criteria, 21 publications were selected.
RESULTS: This systematic review has demonstrated the beneficial impact of music therapy on cognition (memory, attention, language), emotion and behavior (anxiety, depression and agitation) in AD patients.
CONCLUSIONS: Music therapy constitutes a non-pharmacological therapy effective for some cognitive, emotional and behavioral symptoms in patients with AD. However, further investigations and more evidence in this field are needed to claim conclusively the impact of music therapy on this disease.

Entities:  

Mesh:

Year:  2017        PMID: 29235615

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  5 in total

1.  Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease.

Authors:  Liao-Yao Wang; Jian Pei; Yi-Jun Zhan; Yi-Wen Cai
Journal:  Front Aging Neurosci       Date:  2020-11-25       Impact factor: 5.750

2.  Jiedu-Yizhi Formula Improves Cognitive Impairment in an Aβ 25-35-Induced Rat Model of Alzheimer's Disease by Inhibiting Pyroptosis.

Authors:  Jiale Wang; Xiaoting Zhu; Yuhui Li; Pengqi Zhang; Tianye Wang; Mingquan Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-16       Impact factor: 2.629

Review 3.  Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease.

Authors:  Julia Doroszkiewicz; Piotr Mroczko; Agnieszka Kulczyńska-Przybik
Journal:  Curr Alzheimer Res       Date:  2022       Impact factor: 3.040

Review 4.  New Possibilities in the Therapeutic Approach to Alzheimer's Disease.

Authors:  Julia Doroszkiewicz; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 5.  Cognitive and Physical Intervention in Metals' Dysfunction and Neurodegeneration.

Authors:  Anna Jopowicz; Justyna Wiśniowska; Beata Tarnacka
Journal:  Brain Sci       Date:  2022-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.